Structure

Physi-Chem Properties

Molecular Weight:  580.16
Volume:  558.499
LogP:  2.778
LogD:  2.556
LogS:  -4.999
# Rotatable Bonds:  8
TPSA:  192.44
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.135
Synthetic Accessibility Score:  4.267
Fsp3:  0.267
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.176
MDCK Permeability:  1.5336765500251204e-05
Pgp-inhibitor:  0.011
Pgp-substrate:  0.706
Human Intestinal Absorption (HIA):  0.531
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.025
Plasma Protein Binding (PPB):  98.09938049316406%
Volume Distribution (VD):  0.422
Pgp-substrate:  1.8902357816696167%

ADMET: Metabolism

CYP1A2-inhibitor:  0.214
CYP1A2-substrate:  0.024
CYP2C19-inhibitor:  0.428
CYP2C19-substrate:  0.054
CYP2C9-inhibitor:  0.877
CYP2C9-substrate:  0.937
CYP2D6-inhibitor:  0.879
CYP2D6-substrate:  0.239
CYP3A4-inhibitor:  0.54
CYP3A4-substrate:  0.104

ADMET: Excretion

Clearance (CL):  6.725
Half-life (T1/2):  0.556

ADMET: Toxicity

hERG Blockers:  0.018
Human Hepatotoxicity (H-HT):  0.112
Drug-inuced Liver Injury (DILI):  0.956
AMES Toxicity:  0.603
Rat Oral Acute Toxicity:  0.217
Maximum Recommended Daily Dose:  0.035
Skin Sensitization:  0.946
Carcinogencity:  0.715
Eye Corrosion:  0.003
Eye Irritation:  0.908
Respiratory Toxicity:  0.054

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC67134

Natural Product ID:  NPC67134
Common Name*:   Visartiside B
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-[[(2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydrochromen-7-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-phenylprop-2-enoate
Synonyms:   Visartiside B
Standard InCHIKey:  XJWKDASPAHTQCB-SJNSNYLYSA-N
Standard InCHI:  InChI=1S/C30H28O12/c31-18-8-7-16(10-19(18)32)22-13-21(34)26-20(33)11-17(12-23(26)41-22)40-30-29(38)28(37)27(36)24(42-30)14-39-25(35)9-6-15-4-2-1-3-5-15/h1-12,22,24,27-33,36-38H,13-14H2/b9-6+/t22-,24+,27+,28-,29+,30+/m0/s1
SMILES:  O=C(/C=C/c1ccccc1)OC[C@H]1O[C@@H](Oc2cc(O)c3c(c2)O[C@@H](CC3=O)c2ccc(c(c2)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077013
PubChem CID:   46184560
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/S0031-9422(02)00231-5]
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[12377236]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. PMID[20121165]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO539 Picea vulgaris Species Pinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14062 Oophaga speciosa Species Dendrobatidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 25100.0 nM PMID[557138]
NPT113 Cell Line RAW264.7 Mus musculus Activity = 100.0 % PMID[557138]
NPT1 Others Radical scavenging activity ED50 = 34.1 uM PMID[557138]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC67134 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC47140
0.9756 High Similarity NPC476620
0.9756 High Similarity NPC476622
0.9756 High Similarity NPC476621
0.9756 High Similarity NPC476619
0.9756 High Similarity NPC476618
0.9756 High Similarity NPC476623
0.9693 High Similarity NPC472993
0.9691 High Similarity NPC204937
0.9691 High Similarity NPC149011
0.9639 High Similarity NPC469371
0.9636 High Similarity NPC472387
0.9634 High Similarity NPC214621
0.9634 High Similarity NPC34267
0.9634 High Similarity NPC223426
0.9634 High Similarity NPC81042
0.9625 High Similarity NPC29830
0.9625 High Similarity NPC121290
0.9576 High Similarity NPC472991
0.9576 High Similarity NPC472992
0.9576 High Similarity NPC144097
0.9576 High Similarity NPC61904
0.9573 High Similarity NPC172033
0.9573 High Similarity NPC175230
0.9573 High Similarity NPC88560
0.9571 High Similarity NPC51326
0.9571 High Similarity NPC231194
0.9568 High Similarity NPC45400
0.9563 High Similarity NPC472876
0.9518 High Similarity NPC35167
0.9518 High Similarity NPC37668
0.9518 High Similarity NPC217520
0.9518 High Similarity NPC113836
0.9518 High Similarity NPC139571
0.9518 High Similarity NPC253521
0.9509 High Similarity NPC229687
0.9509 High Similarity NPC43587
0.9509 High Similarity NPC105283
0.9506 High Similarity NPC115674
0.9506 High Similarity NPC236934
0.9506 High Similarity NPC5778
0.9506 High Similarity NPC210073
0.9506 High Similarity NPC8856
0.9503 High Similarity NPC168822
0.9464 High Similarity NPC241781
0.9464 High Similarity NPC470718
0.9464 High Similarity NPC162394
0.9464 High Similarity NPC156785
0.9461 High Similarity NPC471030
0.9451 High Similarity NPC105095
0.9451 High Similarity NPC79056
0.9451 High Similarity NPC150767
0.9451 High Similarity NPC78734
0.9451 High Similarity NPC218488
0.9451 High Similarity NPC34287
0.9451 High Similarity NPC44328
0.9451 High Similarity NPC177731
0.9451 High Similarity NPC471416
0.9448 High Similarity NPC116745
0.9448 High Similarity NPC160156
0.9448 High Similarity NPC92565
0.9448 High Similarity NPC229729
0.9444 High Similarity NPC165720
0.9441 High Similarity NPC127782
0.9441 High Similarity NPC300537
0.9441 High Similarity NPC77660
0.9441 High Similarity NPC189142
0.9408 High Similarity NPC25946
0.9408 High Similarity NPC460984
0.9408 High Similarity NPC470720
0.9408 High Similarity NPC470717
0.9408 High Similarity NPC21359
0.9408 High Similarity NPC231254
0.9408 High Similarity NPC223860
0.9408 High Similarity NPC275977
0.9408 High Similarity NPC470713
0.9408 High Similarity NPC249560
0.9401 High Similarity NPC293626
0.9401 High Similarity NPC267680
0.9401 High Similarity NPC477895
0.9401 High Similarity NPC217387
0.9401 High Similarity NPC196127
0.9401 High Similarity NPC258044
0.9398 High Similarity NPC253685
0.9394 High Similarity NPC81332
0.9394 High Similarity NPC262580
0.9394 High Similarity NPC289396
0.9394 High Similarity NPC212038
0.9394 High Similarity NPC256760
0.9394 High Similarity NPC301683
0.9394 High Similarity NPC271848
0.9394 High Similarity NPC472386
0.939 High Similarity NPC86008
0.939 High Similarity NPC195257
0.939 High Similarity NPC270578
0.939 High Similarity NPC209296
0.939 High Similarity NPC471457
0.939 High Similarity NPC52382
0.939 High Similarity NPC293629
0.939 High Similarity NPC170675
0.939 High Similarity NPC112755
0.9383 High Similarity NPC270335
0.9383 High Similarity NPC191306
0.9383 High Similarity NPC19709
0.9383 High Similarity NPC88043
0.9379 High Similarity NPC477628
0.9379 High Similarity NPC270675
0.9379 High Similarity NPC472994
0.9379 High Similarity NPC210961
0.9379 High Similarity NPC195685
0.9379 High Similarity NPC477629
0.9353 High Similarity NPC33083
0.9353 High Similarity NPC295625
0.9353 High Similarity NPC470719
0.9353 High Similarity NPC473554
0.9349 High Similarity NPC135831
0.9349 High Similarity NPC297503
0.9349 High Similarity NPC199172
0.9349 High Similarity NPC35924
0.9349 High Similarity NPC97119
0.9349 High Similarity NPC36138
0.9341 High Similarity NPC89127
0.9341 High Similarity NPC296018
0.9341 High Similarity NPC268533
0.9341 High Similarity NPC154741
0.9341 High Similarity NPC471669
0.9337 High Similarity NPC51774
0.9337 High Similarity NPC239549
0.9337 High Similarity NPC236191
0.9337 High Similarity NPC208668
0.9333 High Similarity NPC67105
0.9333 High Similarity NPC116864
0.9333 High Similarity NPC95866
0.9333 High Similarity NPC156869
0.9333 High Similarity NPC235260
0.9333 High Similarity NPC29958
0.9333 High Similarity NPC259896
0.9333 High Similarity NPC255157
0.9333 High Similarity NPC254855
0.9333 High Similarity NPC21190
0.9333 High Similarity NPC285197
0.9333 High Similarity NPC44558
0.9333 High Similarity NPC474434
0.9333 High Similarity NPC136042
0.9333 High Similarity NPC20505
0.9333 High Similarity NPC183357
0.9333 High Similarity NPC67326
0.9333 High Similarity NPC22195
0.9333 High Similarity NPC155763
0.9333 High Similarity NPC244776
0.9329 High Similarity NPC275454
0.9329 High Similarity NPC477502
0.9325 High Similarity NPC311830
0.9325 High Similarity NPC277205
0.9325 High Similarity NPC22832
0.9321 High Similarity NPC473043
0.9317 High Similarity NPC289346
0.9298 High Similarity NPC105591
0.9298 High Similarity NPC30011
0.9298 High Similarity NPC65489
0.9298 High Similarity NPC97817
0.9298 High Similarity NPC72554
0.9294 High Similarity NPC470416
0.9286 High Similarity NPC173837
0.9286 High Similarity NPC476773
0.9286 High Similarity NPC120952
0.9281 High Similarity NPC294629
0.9277 High Similarity NPC471748
0.9277 High Similarity NPC134532
0.9277 High Similarity NPC60735
0.9277 High Similarity NPC261254
0.9277 High Similarity NPC175107
0.9277 High Similarity NPC235575
0.9277 High Similarity NPC205076
0.9277 High Similarity NPC48773
0.9277 High Similarity NPC3583
0.9277 High Similarity NPC26230
0.9277 High Similarity NPC267254
0.9277 High Similarity NPC155877
0.9277 High Similarity NPC33054
0.9277 High Similarity NPC190003
0.9277 High Similarity NPC471725
0.9277 High Similarity NPC254540
0.9277 High Similarity NPC153755
0.9277 High Similarity NPC307518
0.9277 High Similarity NPC172807
0.9277 High Similarity NPC259152
0.9277 High Similarity NPC211594
0.9277 High Similarity NPC180918
0.9277 High Similarity NPC176740
0.9277 High Similarity NPC203259
0.9273 High Similarity NPC183036
0.9273 High Similarity NPC210042
0.9273 High Similarity NPC138927
0.9273 High Similarity NPC227508
0.9273 High Similarity NPC472383
0.9273 High Similarity NPC472381
0.9273 High Similarity NPC95855
0.9273 High Similarity NPC61791
0.9268 High Similarity NPC56077

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC67134 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9451 High Similarity NPD7074 Phase 3
0.939 High Similarity NPD7054 Approved
0.9333 High Similarity NPD7472 Approved
0.9277 High Similarity NPD6797 Phase 2
0.9222 High Similarity NPD7251 Discontinued
0.9212 High Similarity NPD3818 Discontinued
0.9207 High Similarity NPD6168 Clinical (unspecified phase)
0.9207 High Similarity NPD6166 Phase 2
0.9207 High Similarity NPD6167 Clinical (unspecified phase)
0.9193 High Similarity NPD4381 Clinical (unspecified phase)
0.9167 High Similarity NPD4338 Clinical (unspecified phase)
0.913 High Similarity NPD4868 Clinical (unspecified phase)
0.9053 High Similarity NPD7808 Phase 3
0.8935 High Similarity NPD7993 Clinical (unspecified phase)
0.8827 High Similarity NPD1934 Approved
0.8817 High Similarity NPD7804 Clinical (unspecified phase)
0.8773 High Similarity NPD2393 Clinical (unspecified phase)
0.8663 High Similarity NPD6559 Discontinued
0.8589 High Similarity NPD4380 Phase 2
0.8503 High Similarity NPD7075 Discontinued
0.8494 Intermediate Similarity NPD3817 Phase 2
0.8457 Intermediate Similarity NPD8312 Approved
0.8457 Intermediate Similarity NPD8313 Approved
0.8447 Intermediate Similarity NPD1511 Approved
0.8434 Intermediate Similarity NPD2801 Approved
0.8424 Intermediate Similarity NPD7411 Suspended
0.8382 Intermediate Similarity NPD5844 Phase 1
0.8344 Intermediate Similarity NPD1512 Approved
0.8333 Intermediate Similarity NPD3882 Suspended
0.8323 Intermediate Similarity NPD1465 Phase 2
0.8323 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD5402 Approved
0.8263 Intermediate Similarity NPD6801 Discontinued
0.825 Intermediate Similarity NPD1549 Phase 2
0.8246 Intermediate Similarity NPD6959 Discontinued
0.8242 Intermediate Similarity NPD1653 Approved
0.8232 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8218 Intermediate Similarity NPD7228 Approved
0.8214 Intermediate Similarity NPD7819 Suspended
0.8208 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD6232 Discontinued
0.8187 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD5494 Approved
0.8187 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD5403 Approved
0.8166 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD7473 Discontinued
0.814 Intermediate Similarity NPD7199 Phase 2
0.8122 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.811 Intermediate Similarity NPD6799 Approved
0.8107 Intermediate Similarity NPD8455 Phase 2
0.8063 Intermediate Similarity NPD8151 Discontinued
0.8061 Intermediate Similarity NPD5401 Approved
0.8061 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD3751 Discontinued
0.7965 Intermediate Similarity NPD3749 Approved
0.7963 Intermediate Similarity NPD7266 Discontinued
0.7952 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD1510 Phase 2
0.7943 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD7685 Pre-registration
0.7929 Intermediate Similarity NPD6599 Discontinued
0.7919 Intermediate Similarity NPD6234 Discontinued
0.7907 Intermediate Similarity NPD7768 Phase 2
0.7901 Intermediate Similarity NPD2796 Approved
0.7892 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD3787 Discontinued
0.7857 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7836 Intermediate Similarity NPD37 Approved
0.7818 Intermediate Similarity NPD3750 Approved
0.7812 Intermediate Similarity NPD1613 Approved
0.7812 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD4965 Approved
0.7803 Intermediate Similarity NPD4966 Approved
0.7803 Intermediate Similarity NPD4967 Phase 2
0.7801 Intermediate Similarity NPD7435 Discontinued
0.7795 Intermediate Similarity NPD7783 Phase 2
0.7795 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6190 Approved
0.7758 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD6777 Approved
0.7737 Intermediate Similarity NPD6779 Approved
0.7737 Intermediate Similarity NPD6778 Approved
0.7737 Intermediate Similarity NPD6776 Approved
0.7737 Intermediate Similarity NPD6780 Approved
0.7737 Intermediate Similarity NPD6782 Approved
0.7737 Intermediate Similarity NPD6781 Approved
0.7735 Intermediate Similarity NPD7240 Approved
0.7711 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD4628 Phase 3
0.7702 Intermediate Similarity NPD943 Approved
0.7702 Intermediate Similarity NPD1240 Approved
0.7683 Intermediate Similarity NPD1551 Phase 2
0.7654 Intermediate Similarity NPD230 Phase 1
0.7654 Intermediate Similarity NPD1933 Approved
0.7633 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7617 Intermediate Similarity NPD7698 Approved
0.7617 Intermediate Similarity NPD7697 Approved
0.7617 Intermediate Similarity NPD7696 Phase 3
0.7614 Intermediate Similarity NPD919 Approved
0.7607 Intermediate Similarity NPD1607 Approved
0.759 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD7584 Approved
0.7579 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7577 Intermediate Similarity NPD7871 Phase 2
0.7577 Intermediate Similarity NPD7870 Phase 2
0.7576 Intermediate Similarity NPD2935 Discontinued
0.7563 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD7874 Approved
0.7562 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD7458 Discontinued
0.7551 Intermediate Similarity NPD7701 Phase 2
0.7542 Intermediate Similarity NPD3926 Phase 2
0.7515 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD8320 Phase 1
0.7487 Intermediate Similarity NPD8319 Approved
0.7474 Intermediate Similarity NPD6535 Approved
0.7474 Intermediate Similarity NPD6534 Approved
0.7474 Intermediate Similarity NPD6823 Phase 2
0.7469 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD3226 Approved
0.7457 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD7699 Phase 2
0.7448 Intermediate Similarity NPD7700 Phase 2
0.7439 Intermediate Similarity NPD447 Suspended
0.7436 Intermediate Similarity NPD7680 Approved
0.7433 Intermediate Similarity NPD8150 Discontinued
0.7427 Intermediate Similarity NPD2532 Approved
0.7427 Intermediate Similarity NPD2534 Approved
0.7427 Intermediate Similarity NPD2533 Approved
0.7409 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD3027 Phase 3
0.7391 Intermediate Similarity NPD5953 Discontinued
0.7374 Intermediate Similarity NPD7585 Approved
0.735 Intermediate Similarity NPD7801 Approved
0.7341 Intermediate Similarity NPD920 Approved
0.7333 Intermediate Similarity NPD1247 Approved
0.7326 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7583 Approved
0.731 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7286 Phase 2
0.7282 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7390 Discontinued
0.7267 Intermediate Similarity NPD1203 Approved
0.7256 Intermediate Similarity NPD6798 Discontinued
0.7256 Intermediate Similarity NPD2313 Discontinued
0.7249 Intermediate Similarity NPD8434 Phase 2
0.724 Intermediate Similarity NPD6213 Phase 3
0.724 Intermediate Similarity NPD6212 Phase 3
0.724 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6832 Phase 2
0.7239 Intermediate Similarity NPD4908 Phase 1
0.7235 Intermediate Similarity NPD1243 Approved
0.7219 Intermediate Similarity NPD2346 Discontinued
0.7202 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7033 Discontinued
0.7202 Intermediate Similarity NPD2799 Discontinued
0.7194 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7135 Intermediate Similarity NPD2800 Approved
0.7135 Intermediate Similarity NPD6674 Discontinued
0.7129 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD7549 Discontinued
0.7126 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1091 Approved
0.7125 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD2344 Approved
0.7108 Intermediate Similarity NPD6233 Phase 2
0.7083 Intermediate Similarity NPD4287 Approved
0.7081 Intermediate Similarity NPD9269 Phase 2
0.7074 Intermediate Similarity NPD7038 Approved
0.7074 Intermediate Similarity NPD7039 Approved
0.7065 Intermediate Similarity NPD5242 Approved
0.7059 Intermediate Similarity NPD5406 Approved
0.7059 Intermediate Similarity NPD6100 Approved
0.7059 Intermediate Similarity NPD5404 Approved
0.7059 Intermediate Similarity NPD6099 Approved
0.7059 Intermediate Similarity NPD5408 Approved
0.7059 Intermediate Similarity NPD5405 Approved
0.7056 Intermediate Similarity NPD5353 Approved
0.7041 Intermediate Similarity NPD7097 Phase 1
0.7037 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD1652 Phase 2
0.7029 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD4360 Phase 2
0.7026 Intermediate Similarity NPD4363 Phase 3
0.7024 Intermediate Similarity NPD5124 Phase 1
0.7024 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD2798 Approved
0.7011 Intermediate Similarity NPD5710 Approved
0.7011 Intermediate Similarity NPD5711 Approved
0.7011 Intermediate Similarity NPD7229 Phase 3
0.7 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.6994 Remote Similarity NPD8166 Discontinued
0.699 Remote Similarity NPD7930 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data